Skip to main content
WeightCited

Berberine pour Metabolic Syndrome

A Preuves Plusieurs grands essais cliniques montrent de manière constante des bénéfices significatifs.

Meta-analysis of 12 RCTs (n=1,068) found significant reductions in body weight (2.07 kg), BMI, waist circumference, and triglycerides. Berberine addresses multiple metabolic syndrome components simultaneously through AMPK activation.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'weightcited.com'; const params = 'ingredient\u003Dberberine\u0026condition\u003Dmetabolic\u002Dsyndrome'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

En conclusion

Meta-analysis of 12 RCTs (n=1,068) found significant reductions in body weight (2.07 kg), BMI, waist circumference, and triglycerides. Berberine addresses multiple metabolic syndrome components simultaneously through AMPK activation.

Key Study Findings

Other 6 weeks
Berberine alleviates metabolic dysfunction-associated steatohepatitis by enhancing the abundance of Akkermansia muciniphila.
Dose: None vs: MCD diet MASH model; Abx + FMT experiments Outcome: Hepatic/colonic inflammation, Akkermansia abundance Effet: None None

Population: MCD diet-induced MASH C57BL/6J male mice

Systematic Review n=61
Berberine for prevention of dementia associated with diabetes and its comorbidities: A systematic review.
Dose: None vs: None Outcome: None Effet: None None

Population: Alzheimer's disease patients

Key Statistics

12

Études

1068

Participants

Positive

A

Note

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Posologies couramment utilisées

general:
500 mg 2-3x/day with meals
starting:
500 mg/day and titrate
metabolicsupport:
1,000-1,500 mg/day

Limite supérieure : 1,500 mg/day; GI side effects limit intake; potential drug interactions

Posologies étudiées dans la recherche

Posologie Durée Effet N
None 6 weeks Positive --
None -- Mixed --
None -- Positive 61

Moment optimal de prise : With meals (reduces GI discomfort and synchronizes with postprandial glucose metabolism)

Safety & Side Effects

Effets indésirables signalés

  • Diarrhea
  • Constipation
  • Flatulence
  • Abdominal pain
  • Potential hypoglycemia (when combined with diabetes medications)

Interactions connues

  • Diabetes medications (may potentiate — hypoglycemia risk)
  • CYP3A4 substrates (berberine is a CYP3A4 inhibitor)
  • CYP2D6 substrates
  • Cyclosporine
  • Metformin (additive effects)

Apport maximal tolérable : 1,500 mg/day; GI side effects limit intake; potential drug interactions

Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.

Frequently Asked Questions

Does Berberine help with Metabolic Syndrome?
Based on 12 studies with 1,068 participants, there is strong evidence from multiple clinical trials that Berberine may support Metabolic Syndrome management. Our evidence grade is A (Strong Evidence).
How much Berberine should I take for Metabolic Syndrome?
Studies have used various dosages. A commonly studied range is 500 mg 2-3x/day with meals. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Berberine?
Reported side effects may include Diarrhea, Constipation, Flatulence, Abdominal pain. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Berberine and Metabolic Syndrome?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 12 peer-reviewed studies with 1,068 total participants. The overall direction of effect is positive.

Autres ingrédients pour Metabolic Syndrome

References

  1. [1] Jiahui Xu et al.. J Nutr Biochem. 2025. Berberine alleviates metabolic dysfunction-associated steatohepatitis by enhancing the abundance of Akkermansia muciniphila. doi:10.1016/j.jnutbio.2025.110069 PubMed
  2. [2] Yufan Dai et al.. Braz J Med Biol Res. 2022. The combination of berberine and evodiamine ameliorates high-fat diet-induced non-alcoholic fatty liver disease associated with modulation of gut microbiota in … doi:10.1590/1414-431X2022e12096 PubMed
  3. [3] Noriko Shinjyo et al.. J Integr Med. 2020. Berberine for prevention of dementia associated with diabetes and its comorbidities: A systematic review. doi:10.1016/j.joim.2020.01.004 PubMed

Avertissement FDA: Ces déclarations n'ont pas été évaluées par la Food and Drug Administration. Les produits et informations sur ce site ne sont pas destinés à diagnostiquer, traiter, guérir ou prévenir quelque maladie que ce soit. Les notes de preuve présentées sont basées sur notre analyse de la recherche publiée et évaluée par des pairs et ne constituent pas un avis médical. Consultez toujours votre professionnel de santé avant de commencer tout régime de compléments alimentaires.